FindTrial
Sign In

A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan

A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030719
Enrollment
Unknown
Registered
2020-03-11
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Integrated traditional Chinese and western medicine group:Traditional Chinese medicine and routine treatment of western medicine
Western medicine group:Routine treatment of western medicine

Sponsors

Wuhan Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Comply with the diagnostic criteria for patients with new pneumonia virus in the The Pneumonitis Diagnosis and Treatment Program for Corona Virus Disease 2019(Sixth Edition); (2) Complete clinical data of patients.

Exclusion criteria

Exclusion criteria: (1) Patients who were eventually diagnosed with other bacterial or viral infections; (2) Patients whose data could not be obtained for special reasons.

Design outcomes

Primary

MeasureTime frame
Mortality rate;Common-severe conversion rate;Length of hospital stay.;—

Secondary

MeasureTime frame
Result of nucleic acid test;Changes in imaging;Blood test;—

Countries

China

Contacts

Public ContactWei Li

Wuhan Hospital of Integrated Traditional Chinese and Western Medicine

784404524@qq.com+86 18995598097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026